MAIA raises $1.08M in private placement; warrants corrected to 1-year lockout, 6-year term

MAIA Biotechnology, Inc.

719,999 shares sold at $1.50/share; each with a warrant to buy one share at $2.05.
Warrants exercisable starting 1 year from issuance, expiring 6 years from issuance date.
Directors Stan Smith ($100K) and Ramiro Guerrero ($30K) participated in the offering.
Net proceeds to fund Part C of THIO-101 Phase II trial and working capital.
Closing expected on or about May 7, 2025, subject to customary conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.